Page 24 Bain Capital Healthcare

24
LIFE SCIENCES
“Forward-looking
pharmacists”
STADA’s busy private years
• Delists
• Acquires EMEA rights to anti-
dandruff brand Nizoral
• Moves into biosimilars space with
investment in BIOCEUTICALS
Arzneimittel AG
• Goes large in skin-care with
acquisition of OTC portfolio from
GSK
• Launches Biosimilar Movymia
targeting osteoporosis
• Launches Bortezomib injectable
anti-cancer drug
• Acquires Walmark, a consumer-
facing company in Central Europe
• Invests in Takeda
Quick facts
OVERVIEW
European manufacturer of prescription
generics and over-the-counter medicine
across more than 120 markets
HQ
Frankfurt, Germany
INVESTMENT
2017
INVESTORS
Private Equity
WEBSITE
stada.com
2018
2019
2020
At 122 years old,
Germany-based STADA’s
global business got
a big boost from a
global platform